Avecho Biotechnology Ltd (AVE) - Total Liabilities

Latest as of December 2025: AU$5.55 Million AUD ≈ $3.92 Million USD

Based on the latest financial reports, Avecho Biotechnology Ltd (AVE) has total liabilities worth AU$5.55 Million AUD (≈ $3.92 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore AVE operating cash flow to assess how effectively this company generates cash.

Avecho Biotechnology Ltd - Total Liabilities Trend (1993–2025)

This chart illustrates how Avecho Biotechnology Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Avecho Biotechnology Ltd (AVE) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Avecho Biotechnology Ltd Competitors by Total Liabilities

The table below lists competitors of Avecho Biotechnology Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Kiattana Transport Public Company Limited BK:KIAT	Thailand	฿174.68 Million
DIAMINES AND CHEMICALS ORD (BSE) NSE:DIAMINESQ	India	Rs232.88 Million
Birman Wood and Hardware Ltd TA:BIRM	Israel	ILA317.69 Million
TP ICAP Group PLC LSE:TCAP	UK	GBX6.14 Billion
Heartbeam Inc NASDAQ:BEAT	USA	$2.47 Million
Ekso Bionics Holdings Inc NASDAQ:EKSO	USA	$11.08 Million
GLORY HEALTH IND. HD-001 F:84R	Germany	€44.83 Billion
Norse Atlantic ASA OL:NORSE	Norway	Nkr1.17 Billion

Liability Composition Analysis (1993–2025)

This chart breaks down Avecho Biotechnology Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Avecho Biotechnology Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	9.95	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.56	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.78	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Avecho Biotechnology Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Avecho Biotechnology Ltd (1993–2025)

The table below shows the annual total liabilities of Avecho Biotechnology Ltd from 1993 to 2025.

Year	Total Liabilities	Change
2025-12-31	AU$5.55 Million ≈ $3.92 Million	+221.15%
2024-12-31	AU$1.73 Million ≈ $1.22 Million	+83.43%
2023-12-31	AU$941.54K ≈ $666.20K	+2.27%
2022-12-31	AU$920.66K ≈ $651.42K	+29.79%
2021-12-31	AU$709.36K ≈ $501.92K	+1.31%
2020-12-31	AU$700.17K ≈ $495.41K	+25.90%
2019-12-31	AU$556.12K ≈ $393.49K	-38.35%
2018-12-31	AU$902.04K ≈ $638.25K	-50.87%
2017-12-31	AU$1.84 Million ≈ $1.30 Million	+7.52%
2016-12-31	AU$1.71 Million ≈ $1.21 Million	-5.97%
2015-12-31	AU$1.82 Million ≈ $1.28 Million	-3.04%
2014-12-31	AU$1.87 Million ≈ $1.33 Million	-14.36%
2013-12-31	AU$2.19 Million ≈ $1.55 Million	+44.93%
2012-12-31	AU$1.51 Million ≈ $1.07 Million	-58.44%
2011-12-31	AU$3.63 Million ≈ $2.57 Million	-75.40%
2010-12-31	AU$14.76 Million ≈ $10.44 Million	-15.04%
2009-12-31	AU$17.38 Million ≈ $12.29 Million	-1.48%
2008-12-31	AU$17.64 Million ≈ $12.48 Million	-53.29%
2007-12-31	AU$37.76 Million ≈ $26.72 Million	-0.69%
2006-12-31	AU$38.02 Million ≈ $26.90 Million	-2.35%
2005-12-31	AU$38.94 Million ≈ $27.55 Million	+4702.46%
2004-12-31	AU$810.73K ≈ $573.64K	+3127.69%
2003-12-31	AU$25.12K ≈ $17.77K	-17.24%
2002-12-31	AU$30.35K ≈ $21.47K	-46.21%
2001-12-31	AU$56.42K ≈ $39.92K	-69.54%
2000-12-31	AU$185.25K ≈ $131.08K	+156.71%
1999-12-31	AU$72.16K ≈ $51.06K	+117.59%
1998-12-31	AU$33.16K ≈ $23.47K	-54.87%
1997-12-31	AU$73.48K ≈ $51.99K	-98.74%
1996-12-31	AU$5.84 Million ≈ $4.13 Million	+4.60%
1995-12-31	AU$5.58 Million ≈ $3.95 Million	+1368.16%
1994-12-31	AU$380.00K ≈ $268.87K	-73.95%
1993-12-31	AU$1.46 Million ≈ $1.03 Million	--

About Avecho Biotechnology Ltd

AU:AVE Australia Biotechnology

Market Cap

$28.59 Million

AU$40.41 Million AUD

Market Cap Rank

#23863 Global

#961 in Australia

Share Price

AU$0.01

Change (1 day)

-8.33%

52-Week Range

AU$0.00 - AU$0.01

All Time High

AU$0.04